Search

everythinglearnresearchcommunity

for

Search:↓

Evidence-based urology improved treatment and quality of life for conditions like BPH by shifting from surgery to effective medications like finasteride and dutasteride.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Blocking testosterone action may improve breathing during NREM sleep in healthy men.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

New findings suggest the protein linked to Birt–Hogg–Dubé syndrome is important in cell signaling and could affect treatment understanding.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

The treatment improved prostate health in mice.

Optimized liposomes can improve drug delivery and effectiveness.

Ovarian hyperthecosis can cause high testosterone and symptoms like hair loss, and surgery can help improve these symptoms.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Hair root analysis can effectively detect somatic mosaicism in double cortex syndrome.

UK stem-cell clinics often mislead about treatment safety and effectiveness, needing better regulation.

Most people who volunteered for a health study had medical issues, showing the need for careful screening before trials.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

The grand round helps improve diagnoses and suggests new treatments for hair disorders.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

SHPro® improved urinary symptoms and erectile function in men and is safe.

This is the first known case of parathyroid cancer in a patient with Birt Hogg Dube Syndrome.

PBX1 helps reduce aging and cell death in hair follicle stem cells by decreasing DNA damage, not by improving DNA repair.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Lhx2 is a crucial regulator of the Sonic Hedgehog signaling in early mouse retinal development.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.